|Articles|April 1, 2018
- Pharmaceutical Executive-04-01-2018
- Volume 38
- Issue 4
Pharmaceutical Executive, April 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Rewriting Pharma’s Talent Blueprintover 7 years ago
Trading Big Pharma for Small Startupover 7 years ago
HEOR Education: Evolving the Skill Setover 7 years ago
Drug Marketing and Advertising Under Fireover 7 years ago
A Watchful Eye on AIover 7 years ago
The New Talent Trajectoryover 7 years ago
HBA's Woman of the Year 2018over 7 years ago
The New (Augmented) Reality in the Life Sciencesover 7 years ago
Med Affairs Building Up its Strategic Muscleover 7 years ago
The Top Barriers to Patient PersistenceNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
2
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
3
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
4
FDA Approves Expanded Indication of Jaypirca for Adults with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
5
